TNBCExemestaneVenlafaxineTaxanesIntermediate(11-25)AbemaciclibPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)OlaparibRadiationtherapy2yearsTamoxifenCapecitabineChemoendocrinetherapyEverymonthTDM-1(Ado-trastuzumabemtansine)Pertuzumab1yearLoperamideprophylaxis10yearsAnthracyclinesPembrolizumabLVEFmonitoringTC (docetaxel /cyclophosphamide)AromataseinhibitorsTNBCExemestaneVenlafaxineTaxanesIntermediate(11-25)AbemaciclibPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)OlaparibRadiationtherapy2yearsTamoxifenCapecitabineChemoendocrinetherapyEverymonthTDM-1(Ado-trastuzumabemtansine)Pertuzumab1yearLoperamideprophylaxis10yearsAnthracyclinesPembrolizumabLVEFmonitoringTC (docetaxel /cyclophosphamide)Aromataseinhibitors

Early-Stage Breast Cancer - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. TNBC
  2. Exemestane
  3. Venlafaxine
  4. Taxanes
  5. Intermediate (11-25)
  6. Abemaciclib
  7. Percentage needed to be considered HR+ (adjuvant endocrine therapy considered)
  8. Olaparib
  9. Radiation therapy
  10. 2 years
  11. Tamoxifen
  12. Capecitabine
  13. Chemoendocrine therapy
  14. Every month
  15. TDM-1 (Ado-trastuzumab emtansine)
  16. Pertuzumab
  17. 1 year
  18. Loperamide prophylaxis
  19. 10 years
  20. Anthracyclines
  21. Pembrolizumab
  22. LVEF monitoring
  23. TC (docetaxel / cyclophosphamide)
  24. Aromatase inhibitors